The EUropean TRAnsplantation and INnovation Consortium for Risk Stratification in Kidney Transplant Patients
The EUropean TRAnsplantation and INnovation Consortium for Risk Stratification in Kidney Transplant Patients is a registry-stage clinical asset sponsored by Assistance Publique - Hôpitaux de Paris in Kidney Transplant Rejection, Kidney Transplantation, Risk Stratification, Prognosis. SEO and diligence focus: kidney transplantation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Kidney Transplant Rejection
Modality: RNA therapy
Target: kidney transplantation
Sponsor: Assistance Publique - Hôpitaux de Paris
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: kidney transplantation
View original source fields
Condition raw: Kidney Transplant Rejection, Kidney Transplantation, Risk Stratification, Prognosis
Condition normalized: Kidney Transplant Rejection, Kidney Transplantation, Risk Stratification, Prognosis
Modality raw: RNA therapy
Modality normalized: RNA therapy
Target raw: kidney transplantation
Target normalized: kidney transplantation